1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow Fallopian Tube Diseases: new trials by email Literature Review of Fallopian Tube Diseases trials Research Report on Fallopian Tube Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Bevacizumab - Ovarian Neoplasms, Peritoneal Neoplasms | Phase 4 | Completed | Hoffmann-La Roche | 100 | 2018-12-05 | 2025-06-26 |
| NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma BRCA testing - Ovarian Carcinoma, Fallopian Tube Carcinoma | Phase 4 | Active not recruiting | European Institute of Oncology | 323 | 2018-06-12 | 2025-05-15 |
Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Peritoneal Neoplasms (1)
Adnexal Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Neoplasms by Site (2) · Ovarian Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Bevacizumab (1)
European Institute of Oncology (1) · Hoffmann-La Roche (1)
India (1) · Italy (1)